AY Lee, D Erdemir, AS Myerson - Annual review of chemical …, 2011 - annualreviews.org
Polymorphism in molecular crystals is a prevalent phenomenon and is of great interest to the pharmaceutical community. The solid-state form is a key quality attribute of a crystalline …
N Chieng, T Rades, J Aaltonen - Journal of pharmaceutical and biomedical …, 2011 - Elsevier
Pharmaceutical solids are well known to be able to exist in different solid-state forms and there are a wide variety of solid-state analytical techniques available to characterize …
ML Cheney, N Shan, ER Healey, M Hanna… - Crystal Growth & …, 2010 - ACS Publications
In this contribution, we describe how the supramolecular synthon approach can be used for discovery of novel crystal forms and for enhancing the relevant preclinical properties of a low …
HD Clarke, KK Arora, H Bass, P Kavuru… - Crystal Growth & …, 2010 - ACS Publications
This contribution addresses the role of water molecules in crystal engineering by studying the crystal structures and thermal stabilities of 11 new cocrystal hydrates, all of which were …
Y Han, I Ali, Z Wang, J Cai, S Wu, J Tang, L Zhang… - Physics Reports, 2021 - Elsevier
Quantum mechanics (QM) approaches (DFT, MP2, CCSD (T), etc.) play an important role in calculating molecules and crystals with a high accuracy and acceptable efficiency. In recent …
This review article describes the applications of NMR to the study of polymorphs and related forms (solvates) of organic (especially pharmaceutical) compounds, for which it is of …
M Geppi, G Mollica, S Borsacchi… - Applied Spectroscopy …, 2008 - Taylor & Francis
High‐and low‐resolution solid‐state nuclear magnetic resonance (SSNMR) applications to the study of pharmaceuticals are reviewed. Examples are shown involving the use of mono …
W Gong, PK Mondal, S Ahmadi, Y Wu… - International Journal of …, 2021 - Elsevier
Pharmaceutical cocrystals and salts are extensively researched in recent years due to their ability to tune the physicochemical properties of active pharmaceutical ingredients (APIs). A …
Niclosamide (NCL) is an anthelmintic BCS class II drug of low solubility and high permeability. Pharmaceutical cocrystals of NCL were prepared with GRAS molecules, such …